Multiple sclerosis: Altered glutamate homeostasis in lesions correlates with oligodendrocyre and axonal damage

Annals of Neurology

Volumn 50, Issue 2, 2001, Pages 169-180

  Werner, Peter ^a   Pitt, David ^a   Raine, Cedric S ^a,b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMATE AMMONIA LIGASE; GLUTAMATE DEHYDROGENASE; GLUTAMIC ACID; GLUTAMINASE;

ADULT; AGED; ARTICLE; AXONAL INJURY; CLINICAL ARTICLE; DISEASE ASSOCIATION; FEMALE; HOMEOSTASIS; HUMAN; MALE; MULTIPLE SCLEROSIS; OLIGODENDROGLIA; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; WHITE MATTER;

ADULT; AGED; AXONS; BRAIN; FEMALE; GLUTAMIC ACID; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; OLIGODENDROGLIA;

EID: 0034911054     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.1077     Document Type: Article

References (44)

1. The morbid anatomy of the demyelinative diseases
2. The lesion in multiple sclerosis and chronic relapsing experimental allergic encephalomyelitis: A structural comparison
3. Axonal transection in the lesions of multiple sclerosis
4. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro
5. Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases
6. Antisense knockdown of inducible nitric oxide synthase inhibits induction of experimental autoimmune encephalomyelitis in SJL/J mice
7. Identification of autoantibodies associated with myelin damage in multiple sclerosis
8. Multiple sclerosis and central nervous system demyelination
9. Glutamate excitotoxicity in a model of multiple sclerosis
10. Autoimmune encephalomyelitis ameliorated by AMPA antagonists
11. Multiple approaches to multiple sclerosis
12. Murine brain macrophages induce NMDA receptor mediated neuro-toxicity in vitro by secreting glutamate
13. Glutamate metabolism is down-regulated in astrocytes during experimental allergic encephalomyelitis
14. The neuregulin, glial growth factor 2, diminishes autoimmune demyelination and enhances remyelination in a chronic relapsing model for multiple sclerosis
15. The adhesion molecule and cytokine profile of multiple sclerosis lesions
16. Metabolism of glucose, glutamine, long-chain fatty acids and ketone bodies by murine macrophages
17. Macrophage-induced cytotoxicity of N-methyl-D-aspartate receptor positive neurons involves excitatory amino acids rather than reactive oxygen intermediates and cytokines
18. Regulation of glutaminase activity and glutamine metabolism
19. Neuroaxonal dystrophy in HTLV-1-associated myelopathy/tropical spastic paraparesis: Neuropathologic and neuroimmunologic correlations
20. Tropical spastic paraparesis: A model of virus-induced, cytotoxic T-cell-mediated demyelination?
21. Biochemistry and physiology of brain ammonia
22. Glutamine synthetase in oligodendrocytes and astrocytes: New biochemical and immunocytochemical evidence
23. Multiple sclerosis. Oligodendrocyte survival and proliferation in an active established lesion
24. Multiple sclerosis. Oligodendrocyte proliferation and differentiation in fresh lesions
25. Distinct patterns of multiple sclerosis pathology indicates heterogeneiry in pathogenesis
26. Calcium and neuronal death
27. Cellular localizations of AMPA glutamate receptors within the basal forebrain magnocellular complex of rat and monkey
28. Putative gap junctional communication between axon and regenerating Schwann cells during mammalian peripheral nerve regeneration
29. Amino acid composition of cerebrospinal fluid in acute neuroinfections in children
30. Neurotransmitters in cerebrospinal fluid reflect pathological activity
31. Microglia in cerebellar plaques in Alzheimer's disease
32. Tumor necrosis factor-alpha inhibits glutamate uptake by primary human astrocytes
33. Interleukin-1 beta and tumor necrosis factor-alpha suppress dexamethasone induction of glutamine synthetase in primary mouse astrocytes
34. Chronic inhibition of glutamate update produces a model of slow neurotoxicity
35. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis
36. Abnormal glutamate metabolism in an adult-onset degenerative neurological disorder
37. Role of excitotoxicity in human neurological disease
38. Protein oxidation and aging
39. Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity
40. On how altered glutamate homeostasis may contribute to demyelinating diseases of the CNS
41. Pathophysiology of oligodendroglial excitotoxicity
42. Oligodendrocyte survival, loss and birth in lesions of chronic-stage multiple sclerosis
43. Embryonic stem cell-derived glial precursors: A source of myelinating transplants
44. Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord